Our Pipeline
Our integrated approach is uniquely positioned to transform immunotherapies for cancer. Our initial areas of development will focus on the parallel advancement of Umoja’s core platforms with the goal of integrating these synergistic platforms into therapeutic regimens that can be delivered to any patient, with any tumor, at any time.
